Variant report
Variant | esv16878 |
---|---|
Chromosome Location | chr1:220495388-220499568 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:51)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr1:220495373-220495390 | K562 | blood: | n/a | n/a |
2 | CTCF | chr1:220495340-220495490 | Caco-2 | colon: | n/a | n/a |
3 | CTCF | chr1:220495320-220495470 | GM12864 | blood: | n/a | n/a |
4 | CTCF | chr1:220495255-220495393 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr1:220495250-220495451 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr1:220495260-220495410 | K562 | blood: | n/a | n/a |
7 | CTCF | chr1:220495143-220495598 | K562 | blood: | n/a | n/a |
8 | CTCF | chr1:220495234-220495398 | GM12878 | blood: | n/a | n/a |
9 | CTCF | chr1:220495154-220495540 | MCF-7 | breast: | n/a | n/a |
10 | CTCF | chr1:220495360-220495510 | MCF-7 | breast: | n/a | n/a |
11 | CTCF | chr1:220495260-220495424 | K562 | blood: | n/a | n/a |
12 | CTCF | chr1:220495258-220495435 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr1:220495300-220495450 | HepG2 | liver: | n/a | n/a |
14 | CTCF | chr1:220495330-220495407 | GM12892 | blood: | n/a | n/a |
15 | CTCF | chr1:220495261-220495416 | MCF-7 | breast: | n/a | n/a |
16 | CTCF | chr1:220495280-220495430 | WERI-Rb-1 | eye: | n/a | n/a |
17 | CTCF | chr1:220495256-220495459 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr1:220495214-220495489 | K562 | blood: | n/a | n/a |
19 | CTCF | chr1:220495279-220495403 | MCF-7 | breast: | n/a | n/a |
20 | CTCF | chr1:220495269-220495428 | Hela-S3 | cervix: | n/a | n/a |
21 | CTCF | chr1:220495169-220495527 | K562 | blood: | n/a | n/a |
22 | E2F4 | chr1:220498678-220498745 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr1:220498781-220499384 | MCF10A-Er-Src | breast: | n/a | chr1:220499123-220499131 chr1:220499123-220499131 chr1:220499124-220499131 |
24 | FOS | chr1:220498730-220499422 | MCF10A-Er-Src | breast: | n/a | chr1:220499123-220499131 chr1:220499123-220499131 chr1:220499124-220499131 |
25 | FOS | chr1:220498873-220499360 | MCF10A-Er-Src | breast: | n/a | chr1:220499123-220499131 chr1:220499123-220499131 chr1:220499124-220499131 |
26 | FOS | chr1:220499046-220499256 | MCF10A-Er-Src | breast: | n/a | chr1:220499123-220499131 chr1:220499123-220499131 chr1:220499124-220499131 |
27 | HCFC1 | chr1:220495220-220495395 | K562 | blood: | n/a | n/a |
28 | JUND | chr1:220495346-220495396 | K562 | blood: | n/a | n/a |
29 | MAZ | chr1:220495198-220495470 | K562 | blood: | n/a | n/a |
30 | MYC | chr1:220499039-220499382 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | MYC | chr1:220495340-220495410 | K562 | blood: | n/a | n/a |
32 | POLR2A | chr1:220498450-220499269 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr1:220498567-220498903 | Raji | blood: | n/a | n/a |
34 | POLR2A | chr1:220498335-220498878 | GM12891 | blood: | n/a | n/a |
35 | POLR2A | chr1:220498597-220498870 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | POLR2A | chr1:220498336-220498952 | GM12891 | blood: | n/a | n/a |
37 | POLR2A | chr1:220498684-220498918 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | RAD21 | chr1:220495237-220495431 | K562 | blood: | n/a | n/a |
39 | RAD21 | chr1:220495109-220495507 | H1-hESC | embryonic stem cell: | n/a | chr1:220495229-220495243 |
40 | RAD21 | chr1:220495213-220495410 | Hela-S3 | cervix: | n/a | chr1:220495229-220495243 |
41 | RAD21 | chr1:220495116-220495582 | MCF-7 | breast: | n/a | chr1:220495229-220495243 |
42 | RAD21 | chr1:220495136-220495553 | MCF-7 | breast: | n/a | chr1:220495229-220495243 |
43 | RAD21 | chr1:220495240-220495402 | K562 | blood: | n/a | n/a |
44 | RUNX3 | chr1:220498603-220498938 | GM12878 | blood: | n/a | n/a |
45 | RUNX3 | chr1:220498576-220498942 | GM12878 | blood: | n/a | n/a |
46 | SMC3 | chr1:220495236-220495413 | K562 | blood: | n/a | n/a |
47 | SPI1 | chr1:220498698-220498907 | GM12891 | blood: | n/a | n/a |
48 | STAT3 | chr1:220498749-220499495 | MCF10A-Er-Src | breast: | n/a | chr1:220499273-220499284 chr1:220499166-220499174 chr1:220499164-220499175 |
49 | STAT3 | chr1:220499163-220499235 | MCF10A-Er-Src | breast: | n/a | chr1:220499166-220499174 chr1:220499164-220499175 |
50 | STAT3 | chr1:220498780-220499428 | MCF10A-Er-Src | breast: | n/a | chr1:220499273-220499284 chr1:220499166-220499174 chr1:220499164-220499175 |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:220469373..220470129-chr1:220494958..220495790,3 | MCF-7 | breast: | |
2 | chr1:220491693..220493296-chr1:220495769..220497470,2 | K562 | blood: | |
3 | chr1:220490409..220493296-chr1:220495769..220497672,3 | K562 | blood: | |
4 | chr1:220492579..220494999-chr1:220497676..220499408,2 | MCF-7 | breast: | |
5 | chr1:220469913..220472006-chr1:220498061..220500308,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000232883 | TF binding region |
ENSG00000232883 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2175480 | chr1:220495396-220495397 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs149985747 | chr1:220495409-220495410 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs530303218 | chr1:220495415-220495416 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs546894807 | chr1:220495424-220495425 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs566684987 | chr1:220495430-220495431 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs538838314 | chr1:220495440-220495441 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs558774804 | chr1:220495451-220495452 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs568988477 | chr1:220495478-220495479 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs185159731 | chr1:220495510-220495511 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs554631247 | chr1:220495511-220495512 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs189892141 | chr1:220495515-220495516 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs145229399 | chr1:220495546-220495547 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs11589736 | chr1:220495572-220495573 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs149172489 | chr1:220495575-220495576 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs530740323 | chr1:220495596-220495597 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs546015768 | chr1:220495598-220495599 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs562698062 | chr1:220495620-220495621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531276750 | chr1:220495749-220495750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144807308 | chr1:220495779-220495780 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs561481379 | chr1:220495786-220495787 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs368446409 | chr1:220495789-220495790 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs6541134 | chr1:220495808-220495809 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs560412412 | chr1:220495809-220495810 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs532695954 | chr1:220495834-220495835 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs552335474 | chr1:220495930-220495931 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs569448927 | chr1:220495946-220495947 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs575643902 | chr1:220495982-220495983 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs548665661 | chr1:220495983-220495984 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs568320002 | chr1:220495984-220495985 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs56040283 | chr1:220495999-220496000 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs554252707 | chr1:220496021-220496022 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs147941229 | chr1:220496069-220496070 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs79959303 | chr1:220496075-220496076 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs528183356 | chr1:220496100-220496101 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs114472416 | chr1:220496101-220496102 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs576192184 | chr1:220496132-220496133 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs6541135 | chr1:220496140-220496141 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs6541136 | chr1:220496150-220496151 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs560970455 | chr1:220496152-220496153 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs6541137 | chr1:220496232-220496233 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs540603778 | chr1:220496264-220496265 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs141857108 | chr1:220496343-220496344 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs6673482 | chr1:220496379-220496380 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs569171450 | chr1:220496394-220496395 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs6682177 | chr1:220496424-220496425 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs552472609 | chr1:220496448-220496449 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs531759481 | chr1:220496454-220496455 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs147102560 | chr1:220496456-220496457 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs17007446 | chr1:220496472-220496473 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs151119637 | chr1:220496476-220496477 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Autism | 14699429 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:220487400-220495400 | Weak transcription | Right Atrium | heart |
2 | chr1:220493000-220499600 | Weak transcription | Fetal Heart | heart |
3 | chr1:220495000-220495600 | Enhancers | GM12878-XiMat | blood |
4 | chr1:220495600-220495800 | Weak transcription | Right Atrium | heart |
5 | chr1:220495600-220498800 | Weak transcription | GM12878-XiMat | blood |
6 | chr1:220498400-220498800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
7 | chr1:220498400-220498800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr1:220498400-220499000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr1:220498400-220499000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr1:220498400-220500200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr1:220498800-220499000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr1:220498800-220499000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr1:220498800-220499000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr1:220498800-220499000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr1:220498800-220499200 | Enhancers | Esophagus | oesophagus |
16 | chr1:220498800-220500000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr1:220498800-220500000 | Enhancers | HSMMtube | muscle |
18 | chr1:220498800-220500200 | Enhancers | GM12878-XiMat | blood |
19 | chr1:220498800-220503000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
20 | chr1:220499000-220500000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
21 | chr1:220499000-220500200 | Enhancers | NH-A | brain |
22 | chr1:220499000-220501600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
23 | chr1:220499000-220502600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
24 | chr1:220499000-220509400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
25 | chr1:220499200-220500000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
26 | chr1:220499200-220500600 | Weak transcription | Esophagus | oesophagus |